logo-loader

Tissue Regenix 'making a lot of good work towards commercialisation'

Published: 06:03 02 Jun 2017 EDT

Antony Odell, chief executive of Tissue Regenix PLC (LON:TRX) talks through the firm's results for the year to the end of December.

Growing demand for its Dermapure skin graft helped revenues jump by nearly 80% in the period.

Tissue Regenix Group "has the opportunity to become a global commercial...

Tissue Regenix Group PLC (AIM:TRX, OTC:TSSNF) chief executive Danny Lee and chief financial officer David Cocke speak to Proactive's Thomas Warner after releasing a trading update for 2022. They reveal their highlights from the year before looking ahead to what investors can expect from the...

on 02/02/2023